Literature DB >> 32227120

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Gian Battista Danzi1, Marco Loffi1, Gianluca Galeazzi1, Elisa Gherbesi2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32227120      PMCID: PMC7184406          DOI: 10.1093/eurheartj/ehaa254

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
In a 75-year-old Covid-19-positive woman hospitalized for severe bilateral pneumonia, CT scan documented bilateral pulmonary embolism associated with extensive ground-glass opacifications involving both the lung parenchymas. Acute infections are associated with a transient increased risk of venous thrombo-embolic events. A COVID-19-positive 75-year-old woman, with severe bilateral pneumonia and concomitant acute pulmonary embolism, was hospitalized after 10 days of fever and a recent onset of dyspnoea. She was haemodynamically stable and without strong predisposing risk factors for venous thrombo-embolism. The baseline ECG was normal. A modest leucocytosis was present (11.360/mm2) with increased values of C-reactive protein (180 mg/L), troponin I (3240.4 ng/mL), and D-dimer (21 μg/mL). While on oxygen, arterial blood gas revealed a PaO2 of 78.0 mmHg with a PcO2 of 25.1 mmHg and an sO2 of 95.6%. A right basal infiltrate was evident at the chest X-ray, while echocardiographic evaluation showed a dilated and severely hypokinetic right ventricle with a mean derived pulmonary arterial pressure of 60 mmHg. CT scan documented the presence of a bilateral filling defect diagnostic for pulmonary embolism (Panels A and B; ), associated with extensive ground-glass opacifications involving both the lung parenchymas with predominant consolidation in the posterior basal segment of the left lower lobe (Panels C and D; ). Lower-limb compression ultrasonography was negative. Based on these findings, treatment with low molecular weight heparin, lopinavir/ritonavir, and hydroxychloroquine was started.
In conclusion, the absence of major predisposing factors in this case of diffuse bilateral COVID-19 pneumonia seems to confirm the role of severe infections as a precipitant factor for acute venous thrombo-embolism and the causal relationship. Supplementary material is available at European Heart Journal online. Conflict of interest: none declared. Click here for additional data file.
  266 in total

1.  Pre-existing cardiovascular disease, acute kidney injury, and cardiovascular outcomes in hospitalized blacks with COVID-19 infection.

Authors:  Obiora Egbuche; Opeyemi Jegede; Temidayo Abe; Bivek Wagle; Ky Huynh; Dolphurs Hayes; Martin Luther Campbell; Kenechukwu Mezue; Pradhum Ram; Shirley I Nwokike; Rupak Desai; Valery Effoe; Jacques Kpodonu; Jayne Morgan; Elizabeth Ofili; Anekwe Onwuanyi; Melvin R Echols
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

2.  COVID-19 pneumonia: a risk factor for pulmonary thromboembolism?

Authors:  Dany Jasinowodolinski; Mariana Marins Filisbino; Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2020-06-01       Impact factor: 2.624

3.  Case Series of COVID-19 Presenting with Massive Hemoptysis.

Authors:  Serap Argun Barış; İlkim Sema Coşkun; Gözde Selvi; Haşim Boyacı; İlknur Başyiğit
Journal:  Turk Thorac J       Date:  2020-11-01

4.  Extracorporeal Life Support Organization COVID-19 Interim Guidelines.

Authors:  Kiran Shekar; Jenelle Badulak; Giles Peek; Udo Boeken; Heidi J Dalton; Lovkesh Arora; Bishoy Zakhary; Kollengode Ramanathan; Joanne Starr; Bindu Akkanti; M Velia Antonini; Mark T Ogino; Lakshmi Raman
Journal:  ASAIO J       Date:  2020-04-29       Impact factor: 2.872

5.  D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.

Authors:  Ignasi Garcia-Olivé; Helena Sintes; Joaquim Radua; Jorge Abad Capa; Antoni Rosell
Journal:  Respir Med       Date:  2020-05-13       Impact factor: 3.415

6.  COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

Authors:  Antonio Coppola; Maria Lombardi; Maria I Tassoni; Gaetano Carolla; Maurizio Tala; Rossella Morandini; Oriana Paoletti; Sophie Testa
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

Review 7.  Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.

Authors:  Daniel Lenihan; Joseph Carver; Charles Porter; Jennifer E Liu; Susan Dent; Paaladinesh Thavendiranathan; Joshua D Mitchell; Anju Nohria; Michael G Fradley; Iskra Pusic; Keith Stockerl-Goldstein; Anne Blaes; Alexander R Lyon; Sarju Ganatra; Teresa López-Fernández; Rupal O'Quinn; Giorgio Minotti; Sebastian Szmit; Daniela Cardinale; Jose Alvarez-Cardona; Giuseppe Curigliano; Tomas G Neilan; Joerg Herrmann
Journal:  CA Cancer J Clin       Date:  2020-09-10       Impact factor: 508.702

8.  COVID-19: A Potential Risk Factor for Acute Pulmonary Embolism.

Authors:  Angel I Martin; Gaurav Rao
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Apr-Jun

9.  Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

Authors:  Eleni E Ladikou; Helena Sivaloganathan; Kate M Milne; William E Arter; Roshan Ramasamy; Ramy Saad; Simon M Stoneham; Barbara Philips; Alice C Eziefula; Timothy Chevassut
Journal:  Clin Med (Lond)       Date:  2020-07-21       Impact factor: 2.659

Review 10.  Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications.

Authors:  Margarita V Revzin; Sarah Raza; Robin Warshawsky; Catherine D'Agostino; Neil C Srivastava; Anna S Bader; Ajay Malhotra; Ritesh D Patel; Kan Chen; Christopher Kyriakakos; John S Pellerito
Journal:  Radiographics       Date:  2020-10       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.